
2.88 Delayed Data As of Jun 02 | ![]() Today’s Change | 2.25 Today|||52-Week Range 11.02 | -59.16% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $207.8M |
Kezar Life Sciences, Inc. 4000 Shoreline Court South San Francisco California 94080 |
John Fowler | Chief Executive Officer & Director |
Marc L. Belsky | Chief Financial Officer & Secretary |
Noreen Roth Henig | Chief Medical Officer |
Pattie Chiang | Vice President & Controller |
Andrea Fan | Vice President-Biology |